Goichi Tatsumi

A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers

Noriko Sugino, Masahiro Kawahara, Goichi Tatsumi et al. · Leukemia · 2017 · 73 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

Selective dissociation between LSD1 and GFI1B by a LSD1 inhibitor NCD38 induces the activation of<i>ERG</i>super-enhancer in erythroleukemia cells

Ryusuke Yamamoto, Masahiro Kawahara, Shinji Ito et al. · Oncotarget · 2018 · 33 citations · Full text

LSD1-mediated repression of GFI1 super-enhancer plays an essential role in erythroleukemia

Goichi Tatsumi, Masahiro Kawahara, Ryusuke Yamamoto et al. · Leukemia · 2019 · 26 citations

Signal Transduction, Essential Role, Signaling Pathway +7

Primary Hepatic Lymphoma in a Patient with Rheumatoid Arthritis Treated with Methotrexate

Goichi Tatsumi, Naoya Ukyo, Hirokazu Hirata et al. · Case Reports in Hematology · 2014 · 17 citations · Full text

Mtx Therapy, Immunology, Rheumatoid Arthritis Treated +18

Pharmacological restriction of genomic binding sites redirects PU.1 pioneer transcription factor activity

Samuel J. Taylor, Jacob Stauber, Oliver Bohorquez et al. · Nature Genetics · 2024 · 14 citations · Full text